Intravitreous Ranibizumab As Treatment For Macular Telangiectasia Type 2.

dc.creatorLira, Rodrigo Pessoa Cavalcanti
dc.creatorSilva, Valdir Balarin
dc.creatorCavalcanti, Tiago Marques
dc.creatorde Souza, Ana Catarina Delgado
dc.creatorPinto, Alexandre Paashaus da Costa
dc.date2010-Aug
dc.date2015-11-27T13:18:09Z
dc.date2015-11-27T13:18:09Z
dc.date.accessioned2018-03-29T01:11:26Z
dc.date.available2018-03-29T01:11:26Z
dc.identifierArchives Of Ophthalmology. v. 128, n. 8, p. 1075-8, 2010-Aug.
dc.identifier1538-3601
dc.identifier10.1001/archophthalmol.2010.155
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/20697014
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/198993
dc.identifier20697014
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1299226
dc.description
dc.description128
dc.description1075-8
dc.languageeng
dc.relationArchives Of Ophthalmology
dc.relationArch. Ophthalmol.
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAngiogenesis Inhibitors
dc.subjectAntibodies, Monoclonal
dc.subjectAntibodies, Monoclonal, Humanized
dc.subjectFemale
dc.subjectFluorescein Angiography
dc.subjectHumans
dc.subjectInjections
dc.subjectMiddle Aged
dc.subjectRetina
dc.subjectRetinal Detachment
dc.subjectRetinal Diseases
dc.subjectRetinal Vessels
dc.subjectTelangiectasis
dc.subjectTomography, Optical Coherence
dc.subjectVisual Acuity
dc.subjectVitreous Body
dc.titleIntravitreous Ranibizumab As Treatment For Macular Telangiectasia Type 2.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución